- Roman-Naranjo P:
-
Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Sensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain
Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Granada, Spain
Division of Otolaryngology, Department of Surgery, University of Granada, Granada, Spain
- Parra-Perez AM:
-
Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Granada, Spain
Division of Otolaryngology, Department of Surgery, University of Granada, Granada, Spain
- Escalera-Balsera A:
-
Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Sensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain
Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Granada, Spain
- Soto-Varela A:
-
Division of Otoneurology, Department of Otorhinolaryngology, Complexo Hospitalario Universitario, Santiago de Compostela, Spain
Department of Surgery and Medical-Surgical Specialities, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
- Gallego-Martinez A:
-
Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Sensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain
Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Granada, Spain
- Aran I:
-
Department of Otolaryngology, Complexo Hospitalario de Pontevedra, Pontevedra, Spain
- Perez-Fernandez N:
-
Department of Otorhinolaryngology, Clinica Universidad de Navarra, Madrid, Spain
- Bächinger D:
-
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland, Zurich, Switzerland
- Eckhard AH:
-
Department of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich, Zurich, Switzerland, Zurich, Switzerland
- Gonzalez-Aguado R:
-
Department of Otorhinolaryngology, Hospital Universitario Marques de Valdecilla, Cantabria, Spain
- Frejo L:
-
Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Sensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain
Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Granada, Spain
- Lopez-Escamez JA:
-
Otology & Neurotology Group CTS 495, Department of Genomic Medicine, GENYO, Centre for Genomics and Oncological Research: Pfizer/University of Granada/Andalusian Regional Government, Granada, Spain
Sensorineural Pathology Programme, Centro de Investigación Biomédica en Red en Enfermedades Raras, Madrid, Spain
Department of Otolaryngology, Instituto de Investigación Biosanitaria ibs.Granada, Hospital Universitario Virgen de las Nieves, Universidad de Granada, Granada, Spain
Division of Otolaryngology, Department of Surgery, University of Granada, Granada, Spain